Ucla Department Of Pathology & Laboratory Medicine

UCLA Department of Pathology & Laboratory Medicine, a state-controlled educational institution and child entity of the University of California, Los Angeles system, operates as a federal prime contractor delivering STAT and esoteric reference laboratory testing services, whole exome sequencing, and autopsy services to the Department of Veterans Affairs and the National Institutes of Health. The department competes full-and-open without set-asides, relying on its academic medical center capabilities and specialized diagnostic expertise to secure direct purchase orders and delivery orders from federal health agencies.

UCLA Department of Pathology & Laboratory Medicine is structured as a U.S. government entity within the University of California system, headquartered in Los Angeles, California, and is a child entity of the State of California Controllers Office. The department has served federal customers continuously since 2009, with primary NAICS positioning in Medical Laboratories (26 awards) and Research and Development in Biotechnology (2 awards), and PSC category concentration in Reference Laboratory Testing (25 awards).

Customer concentration is extreme and narrow. The Department of Veterans Affairs Veterans Integrated Service Network 22 (the VA's Greater Los Angeles healthcare network) accounts for 30 of 37 total awards (81%) and $3.8 million of $3.9 million combined potential value (97%). The National Heart, Lung, and Blood Institute accounts for 4 awards and $78 thousand in combined potential value. Four other VA VISNs (Veterans Integrated Service Networks 7, 9, and 12 combined with NHLBI) represent the remaining 3% of potential value across three awards. Recent representative work includes a $247,316 firm fixed-price purchase order from VA VISN 22 awarded March 1, 2026, for STAT and esoteric reference laboratory testing services through February 2027; a $182,433.62 purchase order from VA VISN 22 awarded March 1, 2025; a $316,467.10 purchase order from VA VISN 22 awarded September 1, 2023, for STAT and esoteric reference laboratory testing; and a $21,360 purchase order from NHLBI awarded December 9, 2024, for whole exome library preparation services supporting the Wiestner Laboratory.

UCLA operates under two parent IDIQs with VA: Indefinite Delivery Contract VA26217D0056 (12 task orders, $1.1 million combined potential value) and Indefinite Delivery Contract VA26215D0028 (6 task orders, $211 thousand combined potential value). Activity has declined significantly in recent years — three awards in 2022, two in 2023, one each in 2024 and 2025, and one in early 2026 — with only one award ($247 thousand) facing ultimate completion within the next twenty-four months and therefore minimal recompete exposure in that window. UCLA has no subcontract footprint; all 37 awards are prime.